Ownership: Cameron Collins, Innate Immunotherapeutics

Cameron Collins is an owner of Innate Immunotherapeutics

Title Investor
Is Current yes
Percent Stake 2%
Shares 5.2 Million
Updated about 9 years ago

Source Links